Sanofi, LG Life Sciences lock horns over drug promotion contract
IndustryJan 12, 2016
LG Life Sciences and Sanofi-Aventis Korea, the local affiliate of France-based global health care company Sanofi, are mired in a dispute over a contract to copromote LG’s top-selling diabetes drugs in South Korea. The two parties are at odds over Sanofi’s fulfillment of their contract. The case could be taken to the courts if the two sides fail to reach an agreement, according to industry watchers. The dispute began when the biopharmaceutical unit of LG Group notified Sanofi last month that it w